Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors
摘要:
The latest scientific findings concerning PDE7 and PDE4 inhibition suggest that selective small-molecule inhibitors of both enzymes could provide a novel approach to treat a variety of immunological diseases. In this context, we describe a new series of quinazoline derivatives from quinazolin-4-thiones which include a substituted biphenyl fragment. Some of these compounds show inhibitory potencies at sub-micromolar levels against the catalytic domain of PDE7. (C) 2013 Elsevier Ltd. All rights reserved.
Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors
摘要:
The latest scientific findings concerning PDE7 and PDE4 inhibition suggest that selective small-molecule inhibitors of both enzymes could provide a novel approach to treat a variety of immunological diseases. In this context, we describe a new series of quinazoline derivatives from quinazolin-4-thiones which include a substituted biphenyl fragment. Some of these compounds show inhibitory potencies at sub-micromolar levels against the catalytic domain of PDE7. (C) 2013 Elsevier Ltd. All rights reserved.
Novel benzo-fused lactams that promote the release of growth hormone
申请人:MERCK & CO. INC.
公开号:EP0513974A1
公开(公告)日:1992-11-19
There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositiors containing such benzo-fused lactams as the active ingredient thereof are also disclosed.
[EN] BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE
申请人:——
公开号:WO1992016524A1
公开(公告)日:1992-10-01
[FR] L'invention concerne de nouveaux composés identifiés comme étant des lactames à fusion benzo, qui favorisent la sécrétion de l'hormone de croissance chez les hommes et les animaux. Cette propriété peut être utilisée pour stimuler la croissance d'animaux destinés à la production de produits alimentaires, pour rendre la production de produit à base de viande plus efficace, et chez les hommes, pour développer la taille de ceux affligés par un manque de sécrétion normale de l'hormone de croissance naturelle. L'invention concerne également des compositions favorisant la croissance contenant de tels lactames à fusion benzo comme ingrédient actif. [EN] There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient thereof are also disclosed.
Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors
作者:Ana I. Sánchez、Valentín Martínez-Barrasa、Carolina Burgos、Juan J. Vaquero、Julio Alvarez-Builla、Emma Terricabras、Víctor Segarra
DOI:10.1016/j.bmc.2013.01.067
日期:2013.4
The latest scientific findings concerning PDE7 and PDE4 inhibition suggest that selective small-molecule inhibitors of both enzymes could provide a novel approach to treat a variety of immunological diseases. In this context, we describe a new series of quinazoline derivatives from quinazolin-4-thiones which include a substituted biphenyl fragment. Some of these compounds show inhibitory potencies at sub-micromolar levels against the catalytic domain of PDE7. (C) 2013 Elsevier Ltd. All rights reserved.